INDIVIDUALIZED STEM CELL THERAPY FOR PARKINSON?S DISEASE

帕金森病的个体化干细胞疗法

• 批准号: 8358231
• 负责人: MARINA EMBORG
• 金额: $ 4.3万
• 依托单位: UNIVERSITY OF WISCONSIN-MADISON
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-05-01 至 2012-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8358231
• 关键词: Autologous; Biological Assay; Disease; Funding; Grant; National Center for Research Resources; Parkinson Disease; Primates; Principal Investigator; Research; Research Infrastructure; Resources; Services; Source; United States National Institutes of Health; Wisconsin; cost; induced pluripotent stem cell; restoration; stem cell therapy

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Objective: To assess the feasibility of producing iPS derived Dopaminergic autologous for restoration of Parkinson's disease. This project, funded by a UW-ICTR Type I grant, recently began and progress is forthcoming. This research used WNPRC Assay Services and CPI.

该副本是利用资源的众多研究子项目之一 由NIH/NCRR资助的中心赠款提供。对该子弹的主要支持 而且，副投影的主要研究员可能是其他来源提供的 包括其他NIH来源。 列出的总费用可能 代表subproject使用的中心基础架构的估计量， NCRR赠款不直接向子弹或副本人员提供的直接资金。 目的：评估产生IPS衍生的多巴胺能自体以恢复帕金森氏病的可行性。 该项目由UW-ICTR类型I赠款资助，最近开始了，进度即将到来。 这项研究使用了WNPRC测定服务和CPI。